Skip to content

Clinical study of Hezhong prescription on improving the quality of life of patients with cancer anorexia cachexia syndrome

Clinical study of Hezhong prescription on improving the quality of life of patients with cancer anorexia cachexia syndrome

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003985
Enrollment
Unknown
Registered
2020-09-27
Start date
2020-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

??????????

Interventions

Sponsors

Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Volunteer as a subject and sign an informed consent form. 2. The pathology or cytology is clearly diagnosed as malignant tumor, combined with imaging and other examinations to confirm that the staging is between stage III and In stage IV, there is no restriction on the type of disease or pathological type; aged 20-80 years old; 3. The patient has symptoms of anorexia cachexia syndrome, which meets the diagnostic criteria; visual analog scale for anorexia (VAS) = 40/100mm; Cachexia scores are early and cachexia stage, excluding refractory cachexia; 4. Eastern Cooperative Oncology Group (ECOG) physical status is less than 3; the expected survival time is greater than 4 months; 5. The subject has no serious heart, brain, kidney, hematopoietic system and endocrine system dysfunction (absolutely neutral Granulocyte count (ANC)>1.5*109/L; platelets>100*10^9/L; hemoglobin>=90g/L; total bile Red pigment50ml/min; urine protein test result is small Yu 2+); subjects without mental disorders are conscious and able to cooperate with doctors to complete disease-related examinations Check and evaluate; 6. No obvious eating disorder; 7. Patients who have not received chemotherapy treatment should complete chemotherapy 14 days before randomization in this study; For patients receiving chemotherapy, the chemotherapy regimen should be limited to the standard regimen. During the study period, it is generally not allowed to change the chemotherapy regimen. Treatment plan.

Exclusion criteria

Exclusion criteria: not be addressed

Design outcomes

Primary

MeasureTime frame
EORTC QLQ-C30;Functional evaluation scale for the treatment of anorexia cachexia syndrome;weight;

Secondary

MeasureTime frame
PG-SGA Nutritional Assessment;Clinical symptom questionnaire score;Appetite visual analog scale;Serum albumin;

Countries

China

Contacts

Public ContactLINJIE RUAN

Hospital of Chengdu University of Traditional Chinese Medicine

rlj1011@163.com+86 18408257016

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026